Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes

Diabetes Care(2021)10.2337/dc21-0065Source: DataRank Database

Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes is a research paper published in Diabetes Care (2021). On theSindex it has a DataRank of 0. It has been cited 61 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access61 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (39 grants)Impact (FWCI 3.41)OA: bronzeTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Trine Julie Abrahamsen,G. Caleb Alexander ORCID,Tellen D. Bennett ORCID,Christopher G. Chute ORCID,Melissa A Haendel ORCID

Live enrichment

PubMed:34135013 PMC:PMC8323175 OpenAlex:https://openalex.org/W3170966862

NCATS NIH HHS

Grant: UL1 TR001420

NCATS NIH HHS

Grant: UL1 TR001450

NCATS NIH HHS

Grant: UL1 TR001453

NCATS NIH HHS

Grant: UL1 TR002014

NCATS NIH HHS

Grant: UL1 TR002373

NCATS NIH HHS

Grant: UL1 TR002489

NCATS NIH HHS

Grant: UL1 TR002535

NCATS NIH HHS

Grant: UL1 TR002538

NCATS NIH HHS

Grant: UL1 TR002736

NCATS NIH HHS

Grant: UL1 TR003098

NHLBI NIH HHS

Grant: R01 HL118255

NCATS NIH HHS

Grant: U24 TR002306

NCATS NIH HHS

Grant: UL1 TR001855

NCATS NIH HHS

Grant: UL1 TR002319

NCATS NIH HHS

Grant: UL1 TR002733

NCATS NIH HHS

Grant: UL1 TR003107

NCATS NIH HHS

Grant: UL1 TR002345

NCATS NIH HHS

Grant: UL1 TR002377

NCATS NIH HHS

Grant: UL1 TR002389

NCATS NIH HHS

Grant: UL1 TR001422

NCATS NIH HHS

Grant: UL1 TR002537

NIGMS NIH HHS

Grant: P20 GM103423

NCATS NIH HHS

Grant: UL1 TR001876

NCATS NIH HHS

Grant: UL1 TR002003

NCATS NIH HHS

Grant: UL1 TR002494

NIDDK NIH HHS

Grant: P30 DK124723

NIA NIH HHS

Grant: R01 AG056479

NIGMS NIH HHS

Grant: U54 GM115458

NCATS NIH HHS

Grant: UL1 TR001998

NCATS NIH HHS

Grant: UL1 TR002240

NCATS NIH HHS

Grant: UL1 TR002544

NCATS NIH HHS

Grant: UL1 TR002553

NCATS NIH HHS

Grant: UL1 TR002649

NIMHD NIH HHS

Grant: R01 MD011680

NCATS NIH HHS

Grant: UL1 TR003015

NCATS NIH HHS

Grant: UL1 TR003096

NIDDK NIH HHS

Grant: F30 DK113728

NIGMS NIH HHS

Grant: U54 GM104942

NCATS NIH HHS

Grant: UL1 TR001439

FWCI

3.41

Citation Percentile

0.9%

Citation Trend

2014

2021

2022

2023

2024

2025

2026

bronzeLicense: cc-by-nc-sa

journalhttps://diabetesjournals.org/care/article-pdf/44/7/1564/633039/dc210065.pdf

publisherhttps://diabetesjournals.org/care/article-pdf/44/7/1564/633039/dc210065.pdf

journalhttps://doi.org/10.2337/dc21-0065

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34135013

https://escholarship.umassmed.edu/umccts_pubs/257

Fields of Study

COVID-19 Clinical Research StudiesDiabetes Treatment and ManagementSARS-CoV-2 and COVID-19 ResearchAdultAgedCOVID-19Diabetes Mellitus, Type 2FemaleHumansLongitudinal StudiesMaleMiddle AgedSodium-Glucose Transporter 2 InhibitorsUnited StatesGlucagon-Like Peptide-1 Receptor Agonists

MeSH Terms

Glucagon-Like Peptide-1 ReceptorSodium-Glucose Transporter 2 InhibitorsCOVID-19Glucagon-Like Peptide-1 Receptor AgonistsAdultAgedDiabetes Mellitus, Type 2FemaleHumansLongitudinal StudiesMaleMiddle AgedUnited States

Keywords

MedicineInternal medicineDipeptidyl peptidase-4Odds ratioDiabetes mellitusGlucagon-like peptide 1 receptorCohort studyCohortType 2 diabetesAgonistEndocrinologyReceptor

Sustainable Development Goals

SDG 0: Good health and well-being

Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes

FAIR Checklist

Authors (14)

Funding (39 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)